Biocryst Pharmaceuticals (BCRX) Inventory (2010 - 2026)

Biocryst Pharmaceuticals' Inventory history runs 15 years deep, the most recent figure standing at $6.0 million for Q1 2026.

• Quarterly Inventory fell 12.92% year-over-year to $6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (down 12.92% YoY) and the FY2025 annual result came in at $5.4 million, down 33.25% from the prior year.
• Inventory was $6.0 million for Q1 2026 at Biocryst Pharmaceuticals, up from $5.4 million in the prior quarter.
• Across five years, Inventory topped out at $29.8 million in Q1 2024 and bottomed at $4.4 million in Q2 2024.
• A 5-year average of $16.8 million and a median of $16.4 million in 2022 frame the typical range for Inventory.
• Annual changes were most pronounced in 2022 — Inventory surged 204.61% — and 2024, when it slumped 83.54%.
• Biocryst Pharmaceuticals' Inventory stood at $27.5 million in 2022, then increased by 4.18% to $28.7 million in 2023, then sank by 71.81% to $8.1 million in 2024, then plunged by 33.25% to $5.4 million in 2025, then climbed by 10.87% to $6.0 million in 2026.
• Business Quant data shows BCRX's Inventory at $6.0 million in Q1 2026, $5.4 million in Q4 2025, and $5.2 million in Q3 2025.